stockrowAquestive Therapeutics, Inc. (AQST) vs Kamada Ltd. (KMDA)
- Aquestive Therapeutics, Inc. AQST 3.64 −4.21%
- Kamada Ltd. KMDA 6.89 −7.14%
Aquestive Therapeutics, Inc. and Kamada Ltd. are both Drug Manufacturers Specialty & Generic companies. Aquestive Therapeutics, Inc. is the larger, with a market value of $460.0M against $396.3M — 1.2× the size. Aquestive Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Kamada Ltd. trades at 18.1×. Kamada Ltd. grew revenue faster over the last twelve months: 13.2% against 12.5%. Kamada Ltd. has the higher net margin (11.6% vs −162.3%) and the higher return on invested capital (8.47% vs 0.00%). Across the 18 metrics below, Kamada Ltd. leads on 14 and Aquestive Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | AQST | KMDA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 65.34% | 40.82% | 53.51% |
| Operating margin | (114.12%) | 14.51% | 0.00% |
| Net margin | (162.33%) | 11.60% | (2.45%) |
| Free cash flow margin | (83.33%) | 13.72% | 0.00% |
| Return on equity | 211.59% | 8.40% | (0.80%) |
| Return on assets | (56.05%) | 5.92% | (1.67%) |
| Return on invested capital | 0.00% | 8.47% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack